Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout

BB-1701

Product Sizes
1 mg
£ POA
HY-177414-1MG
5 mg
£ POA
HY-177414-5MG
10 mg
£ POA
HY-177414-10MG
25 mg
£ POA
HY-177414-25MG
About this Product
SKU:
HY-177414
Extra Details:
BB-1701 is an anti-HER2 antibody-drug conjugate (ADC). BB-1701 is composed of a humanized anti-HER2 antibody (Trastuzumab) (HY-P9907); a linker (Mal-PEG2-VCP); a microtubule inhibitor (Eribulin) (HY-13442); and the drug-linker conjugate for ADC is Mal-PEG2-VCP-Eribulin (HY-128870). BB-1701 has a potent cytotoxicity and bystander effects on tumors with heterogeneous target expression. BB-1701 significantly induces immunogenic cell death and the activation of the immune[1].
Research Area:
Cancer; Inflammation/Immunology
Shipping Conditions:
Ambient
Type:
Proteins, Peptides, Small Molecules & Other Biomolecules: Conjugated Protein
Price enquiry form